Intercept Pharmaceuticals reported $87.82M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Acorda Therapeutics ACOR:US $ 16.57M 16.2M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amarin AMRN:US $ 72.39M 41.46M
Amgen AMGN:US $ 4677M 451M
AstraZeneca AZN:LN 8.94B 2.9B
Biogen BIIB:US $ 1777.9M 295.8M
Bristol Myers Squibb BMY:US $ 9177M 452M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Gilead Sciences GILD:US $ 5166M 549M
GlaxoSmithKline GSK:LN 6.14B 283M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
IONIS PHARMACEUT IONS:US $ 438M 307.99M
Moderna Inc MRNA:US 5.05B 1.21B
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Novartis NOVN:VX 9.52B 3M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
YTE INCY:US $ 696.02M 128.26M